Evidence map›Paper›PMID 21127491›Full record

ArticleNature protocols2010

Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection.

Mark A Skidmore, Scott E Guimond, Audrey F Dumax-Vorzet, Edwin A Yates, Jeremy E Turnbull

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Glycosaminoglycanomics: where we are.Glycoconjugate journal · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Capillary electrophoresis for total glycosaminoglycan analysis.Analytical and bioanalytical chemistry · 2014
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mark A SkidmoreCentre for Glycobiology, Institute of Integrative Biology, University of Liverpool, Liverpool, UK.
Scott E Guimond
Audrey F Dumax-Vorzet
Edwin A Yates
Jeremy E Turnbull

Funding

Biotechnology and Biological Sciences Research Council BB/D006325/1Medical Research Council G117/423Wellcome Trust
6 · The paper itself

Abstract

One of the first steps in characterizing heparan sulfate (HS) and its close relative heparin is to conduct disaccharide composition analysis. This provides an overall picture of the structure of the polysaccharide in terms of its constituent disaccharides. This is of importance, for example, in the initial characterization of spatially and temporally regulated structures. Two protocols for conducting disaccharide analysis are presented here, both exploiting exhaustive digestion of the polysaccharide, yielding constituent disaccharides, by bacterial heparin lyases. The first method, suitable for microgram quantities of material, relies on the separation of the disaccharides by high-performance liquid chromatography (HPLC) coupled to ultraviolet absorbance detection and can be performed in 2 d. The second exploits reducing end-labeling with the fluorophore BODIPY hydrazide, separation by HPLC, and subsequent fluorescence detection and quantitation. The latter is a high-sensitivity method that requires nanograms of starting material and has a detection limit in the low fmol range, and is thus the most sensitive method for disaccharide compositional analysis of HS yet reported. Fluorescence detection can be routinely carried out in 3 d.

Indexed as

Boron CompoundsChromatography, High Pressure LiquidDisaccharidesFluorescent DyesHeparan SulfateHeparinSpectrophotometry, Ultraviolet4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsDisaccharidesFluorescent DyesHeparan SulfateHeparin

Identifiers

PMID21127491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.